
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic... Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.55 | -13.5135135135 | 4.07 | 4.5 | 3.5 | 522774 | 4.21993049 | CS |
4 | 0.65 | 22.6480836237 | 2.87 | 7.31 | 2.5 | 7320841 | 4.50774779 | CS |
12 | 0.72 | 25.7142857143 | 2.8 | 7.31 | 2.5 | 2571717 | 4.45918165 | CS |
26 | 0.192 | 5.76923076923 | 3.328 | 7.31 | 2.21 | 1688002 | 4.1137718 | CS |
52 | -4.48 | -56 | 8 | 12 | 2.21 | 1691952 | 5.62146952 | CS |
156 | -52.64 | -93.7321937322 | 56.16 | 61.76 | 2.21 | 989935 | 8.7654027 | CS |
260 | -52.64 | -93.7321937322 | 56.16 | 61.76 | 2.21 | 989935 | 8.7654027 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관